Company Overview: Relmada

Industry News

20 Sep

Relmada Therapeutics to Present at the 2016 Aegis Growth Conference

NEW YORK, Sept. 20, 2016 /PRNewswire/ — Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that the Company will present at the 2016 Aegis Growth Conference being held September 20-22, 2016 at The Encore at Wynn...

Read more

6 Jul

Relmada Therapeutics Secures First European Patent Covering LevoCap ER

Issued patent covers Relmada’s SECUREL™ technology platform and lead pain therapy product candidate LevoCap ER  NEW YORK, July 6, 2016 /PRNewswire/ — Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, announced today that it has been granted a patent...

Read more

7 Jun

Relmada Therapeutics’ d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia

Relmada advancing clinical development plans for d-Methadone in treatment of neuropathic pain and depression. NEW YORK, June 7, 2016 /PRNewswire/ — Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that d-Methadone (dextromethadone, REL-1017), a N-methyl-d-aspartate (NMDA) receptor antagonist in development...

Read more

1 Jun

Relmada Therapeutics to Present at the LD Micro Invitational Conference

Company Presentation on June 7, 2016 at 1:30 p.m. Pacific Time. NEW YORK, June 1, 2016 /PRNewswire/ — Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it will present at the LD Micro Invitational Conference on Tuesday, June 7,...

Read more

26 May

Relmada Therapeutics to Present at the 5th Annual Marcum MicroCap Conference

Company Presentation on June 2, 2016 at 11:00 a.m. Eastern Time. NEW YORK, May 26, 2016 /PRNewswire/ — Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it will present at the 5th Annual Marcum MicroCap Conference on Thursday, June 2,...

Read more

Page 1 of 612345...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address